Lysine Targeting Group‐Transfer Chimeras for Proximity Induction

S Sameek Singh (Chemical Biology and Therapeutics Science) K Kien Tran (Chemical Biology and Therapeutics Science) E Endri Karaj (Chemical Biology and Therapeutics Science Broad Institute of MIT and Harvard Cambridge MA 02142 USA) B Basudeb Mondal (Chemical Biology and Therapeutics Science Broad Institute of MIT and Harvard Cambridge MA 02142 USA) W Wenzhi Tian (Chemical Biology and Therapeutics Science) S Surached Siriwongsup (Department of Cancer Biology) S Shaimaa H. Sindi (Chemical Biology and Therapeutics Science Broad Institute of MIT and Harvard Cambridge MA 02142 USA) U Uttam Dhawa (Chemical Biology and Therapeutics Science Broad Institute of MIT and Harvard Cambridge MA 02142 USA) K Kaushik Pal V Veronika M. Shoba (Chemical Biology and Therapeutics Science Broad Institute of MIT and Harvard Cambridge MA 02142 USA) S Sunny Shi (Chemical Biology and Therapeutics Science Broad Institute of MIT and Harvard Cambridge MA 02142 USA) A Anna Lian (Department of Cancer Biology Dana‐Farber Cancer Institute Boston MA 02215 USA) J Jody Mou (Department of Cancer Biology Dana‐Farber Cancer Institute Boston MA 02215 USA) M Myeonghoon Han (Department of Genetics, Blavatnik Institute, Harvard Medical School) P Prashant Singh (Ames National Laboratory) N Nicholas F. Polizzi A Amit Choudhary (Chemical Biology and Therapeutics Science)

Abstract

Abstract Nature employs post‐translational modifications (PTMs) to induce proximity between proteins by engendering new interactions. Furthermore, we find that protein ligands are invariably proximal to a lysine. Inspired by these two observations, we developed group‐transfer chimeras (GRCs) that append a moiety‐of‐interest to the lysine side chain. GRCs employ a protein's ligand and a handle with a transferase ‐type reactivity to modify the proximal lysine. Contemporary lysine‐targeting group‐transfer handles were incompatible with GRCs due to their hydrolytic instability, large size, high reactivity, and synthetic incompatibility with diverse ligands. Accordingly, we developed an N ‐( su lfonyl)‐ N ‐(tri f luoroethyl)‐ethan a mide (SuFA) handle that is stable, small, and exhibits tunable reactivity and synthetic compatibility with diverse ligands and proteins. Using GRCs that group‐transfer binders of tags (e.g., HaloTag, FKBP) onto proteins overexpressed in cancer cells, we displayed these binders on the surface of the cancer cell. With a un iversal T cell e ngager (UniTE) that binds to the displayed ligands and T cells, these GRCs induced proximity between cancer cells and cytotoxic T cells, leading to the latter's activation. We envision the GRC platform to find utility in basic research and biomedicine.

Article Details

Volume / Issue Vol. 65, Issue 13
Published March 23, 2026
ISSN 1433-7851
Publisher Wiley

Journal Info

Angewandte Chemie International Edition

Wiley

ISSN: 1433-7851 Physical Sciences

Authors (17)

S

Sameek Singh

Chemical Biology and Therapeutics Science

K

Kien Tran

Chemical Biology and Therapeutics Science

E

Endri Karaj

Chemical Biology and Therapeutics Science Broad Institute of MIT and Harvard Cambridge MA 02142 USA

B

Basudeb Mondal

Chemical Biology and Therapeutics Science Broad Institute of MIT and Harvard Cambridge MA 02142 USA

W

Wenzhi Tian

Chemical Biology and Therapeutics Science

S

Surached Siriwongsup

Department of Cancer Biology

S

Shaimaa H. Sindi

Chemical Biology and Therapeutics Science Broad Institute of MIT and Harvard Cambridge MA 02142 USA

U

Uttam Dhawa

Chemical Biology and Therapeutics Science Broad Institute of MIT and Harvard Cambridge MA 02142 USA

K

Kaushik Pal

V

Veronika M. Shoba

Chemical Biology and Therapeutics Science Broad Institute of MIT and Harvard Cambridge MA 02142 USA

S

Sunny Shi

Chemical Biology and Therapeutics Science Broad Institute of MIT and Harvard Cambridge MA 02142 USA

A

Anna Lian

Department of Cancer Biology Dana‐Farber Cancer Institute Boston MA 02215 USA

J

Jody Mou

Department of Cancer Biology Dana‐Farber Cancer Institute Boston MA 02215 USA

M

Myeonghoon Han

Department of Genetics, Blavatnik Institute, Harvard Medical School

P

Prashant Singh

Ames National Laboratory

N

Nicholas F. Polizzi

A

Amit Choudhary

Chemical Biology and Therapeutics Science